Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2014 09:00 ET | Source: Nuvilex, Inc.

Nuvilex Funding Has Investors Preparing for Milestone Announcements in Late-Phase Clinical Trials

NEW YORK, NY--(Marketwired - Mar 3, 2014) - Nuvilex (OTCQB: NVLX) investors who have patiently waited for the R&D biotech to reach a point where late-phase clinical trials were a reality, are...
February 24, 2014 09:00 ET | Source: Nuvilex, Inc.

Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly

NEW YORK, NY--(Marketwired - Feb 24, 2014) - Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be...
February 21, 2014 09:00 ET | Source: Nuvilex, Inc.

Move Over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials

NEW YORK, NY--(Marketwired - Feb 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) just became relevant in the biotech industry. The company can now move forward with its clinical trials for the...
October 17, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc.'s COO, Dr. Gerald Crabtree, Interviews With Stock Market Media Group

NEW YORK, NY--(Marketwired - Oct 17, 2013) - Nuvilex Inc.'s, (OTCQB: NVLX) Chief Operating Officer, Dr. Gerald Crabtree sat down for an interview with Stock Market Media Group, a research and...